BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7288605)

  • 1. Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration.
    Kaufman RD; Gabathuler ML; Bellville JW
    J Pharmacol Exp Ther; 1981 Oct; 219(1):156-62. PubMed ID: 7288605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory depression of intravenous hydroxyzine in man: potency, duration, and lack of reversal by naloxone.
    Gabathuler ML; Kaufman RD
    Anesth Analg; 1981 Sep; 60(9):634-7. PubMed ID: 7196705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine.
    Tallarida RJ; Harakal C; Maslow J; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):38-45. PubMed ID: 660555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of nalbuphine to antagonize morphine: a double-blind comparison with naloxone.
    Bailey PL; Clark NJ; Pace NL; Isern M; Stanley TH
    Anesth Analg; 1986 Jun; 65(6):605-11. PubMed ID: 3085551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
    Shannon HE; Cone EJ; Gorodetzky CW
    J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central effects of morphine on fetal breathing movements in the fetal sheep.
    Bennet L; Johnston BM; Gluckman PD
    J Dev Physiol; 1986 Aug; 8(4):297-305. PubMed ID: 3760485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miosis and fluctuation in the rabbit pupil: effects of morphine and naloxone.
    Tallarida RJ; Kramer MS; Roy JW; Kester RA; Murray RB; Adler MW
    J Pharmacol Exp Ther; 1977 Jun; 201(3):587-92. PubMed ID: 864597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone blockade of morphine analgesia: a dose-effect study of duration and magnitude.
    Markowitz R; Jacobson J; Bain G; Kornetsky C
    J Pharmacol Exp Ther; 1976 Nov; 199(2):385-8. PubMed ID: 978492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal factors influencing the development of acute tolerance to opiates.
    Hovav E; Weinstock M
    J Pharmacol Exp Ther; 1987 Jul; 242(1):251-6. PubMed ID: 3612531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
    Lange DG; Fujimoto JM; Roerig S; Wang RI
    Drug Metab Dispos; 1977; 5(2):167-73. PubMed ID: 15809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal.
    Rawal N; Möllefors K; Axelsson K; Lingårdh G; Widman B
    Anesth Analg; 1983 Jul; 62(7):641-7. PubMed ID: 6859567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone for antagonism of morphine-induced respiratory depression.
    Longnecker DE; Grazis PA; Eggers GW
    Anesth Analg; 1973; 52(3):447-53. PubMed ID: 4736000
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of morphine anesthesia with naloxone.
    Johnstone RE; Jobes DR; Kennell EM; Behar MG; Smith TC
    Anesthesiology; 1974 Oct; 41(4):361-7. PubMed ID: 4415623
    [No Abstract]   [Full Text] [Related]  

  • 17. Naloxone and pentazocine given after morphine.
    Cardan E; Hagel M; Roth A
    Acta Anaesthesiol Belg; 1984; 35 Suppl():265-70. PubMed ID: 6516735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.
    Marsch LA; Bickel WK; Badger GJ; Rathmell JP; Swedberg MD; Jonzon B; Norsten-Höög C
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1056-65. PubMed ID: 11714895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of flumazenil or bicuculline on the respiratory depression by morphine].
    Kasaba T; Takeshita M; Takasaki M
    Masui; 1998 Apr; 47(4):414-9. PubMed ID: 9594513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.